Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Marinos Dalakas MD, FAAN
Marinos C. Dalakas MD, FAAN Advisory Board
Nina Schor MD, PhD
Nina F. Schor MD, PhD Advisory Board
Avindra Nath MD
Avindra Nath MD Associate Editor
See All Experts
Published in Neurology

Journal Scan / Research · October 11, 2021

Immunotherapeutic Management of NMDAR Antibody Encephalitis

JAMA Neurology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Michael Kornberg MD, PhD

JAMA Neurology
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis
JAMA Neurol 2021 Sep 20;[EPub Ahead of Print], M Nosadini, M Eyre, E Molteni, T Thomas, SR Irani, J Dalmau, RC Dale, M Lim, , B Anlar, T Armangue, S Benseler, T Cellucci, K Deiva, W Gallentine, G Gombolay, MP Gorman, Y Hacohen, Y Jiang, BC Lim, E Muscal, A Ndondo, R Neuteboom, K Rostásy, H Sakuma, S Sartori, S Sharma, SN Tenembaum, HA Van Mater, E Wells, R Wickstrom, AK Yeshokumar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated